Surrogate markers for cardiovascular disease: structural markers.
about
Marital quality and health: a meta-analytic reviewWhat is the best strategy for reducing deaths from heart disease?New frontiers in obstructive sleep apnoeaA Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal StudyCoronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.Which Is the Ideal Marker for Early Atherosclerosis in Obstructive Sleep Apnea (OSA) - Carotid Intima-Media Thickness or Mean Platelet Volume?Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA).Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes.Airborne particulate matter exposure and urinary albumin excretion: the Multi-Ethnic Study of Atherosclerosis.Race/ethnic and sex differences in large and small artery elasticity--results of the multi-ethnic study of atherosclerosis (MESA).Bilirubin Level is Associated with Left Ventricular Hypertrophy Independent of Blood Pressure in Previously Untreated Hypertensive PatientsComparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease.Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study.Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetesCarotid Doppler ultrasound evaluation in patients with pulsatile tinnitusLong-term effect of specific treatment of primary aldosteronism on carotid intima-media thicknessThe relationship between plasma and salivary NOx.Acute effects of beer on endothelial function and hemodynamics: a single-blind, crossover study in healthy volunteers.Association between Metabolic Components and Subclinical Atherosclerosis in Korean AdultsUltrasound-detected carotid plaque as a predictor of cardiovascular events.Early detection and management of the high-risk patient with elevated blood pressure.Association of Thoracic Aorta Calcium Score With Exercise Blood Pressure Response and Clinical Outcomes in Elderly Individuals: Differential Impact of Aorta Calcification Compared With Coronary Artery Calcification.Identifying early cardiovascular disease to target candidates for treatment.The Value of Elastic Modulus Index as a Novel Surrogate Marker for Cardiovascular Risk Stratification by Dimensional Speckle-Tracking Carotid Ultrasonography.Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis.Cardiac markers: a clear cause for point-of-care testing.Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.Managing cardiovascular and renal risk: the potential of direct renin inhibition.The association of night-time systolic blood pressure with ultrasound markers of subclinical cardiac and vascular disease.Coronary heart disease risk factors in college students.Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.New class of agents for treatment of hypertension: focus on direct renin inhibition.When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project.Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis.The clinical significance of carotid intima-media thickness in cardiovascular diseases: a survey in Beijing.Sesame oil consumption exerts a beneficial effect on endothelial function in hypertensive men.Nitroso-redox imbalance affects cardiac structure and function.Relationship between high density lipoprotein antioxidant activity and carotid arterial intima-media thickness in patients with essential hypertension.Association between brachial-ankle pulse wave velocity and 3-year mortality in community-dwelling older adults.Cardio-renal protection with aliskiren, a direct renin inhibitor, in the ASPIRE HIGHER program.
P2860
Q24626999-833E03FA-60B9-492E-8BC8-77EC9EE7C12CQ24792163-372D54B1-4C0D-4B09-8A88-113D9410D71EQ26823972-A78BE331-0DD8-48CD-8DB1-225512346ED6Q30381312-E7E0A626-0CB8-404E-A0B0-8F3EB86616B6Q30426026-040DEBA2-2125-48F4-AB5C-6D746D61219BQ33561792-4D5AE061-74D9-47BA-8378-16BE7BB6E080Q33805959-78B947C4-8ABA-420F-82AF-F7E953DD77ECQ33904510-7087E18B-2A71-416D-90C4-A5364A87ECF6Q33946779-F990A509-2220-4A81-ACA2-176B7F6391FEQ34076748-4A188705-636F-492E-BFC3-DB07BF738734Q34269653-BE01B16F-C993-4CBC-B475-30985FAF9015Q34374986-581B1455-CCEA-423F-B542-2C48634F21E2Q34444470-5381464A-9A98-4363-8D54-1F901E57B2C1Q34721194-DD722DDC-8E4B-45E5-A44E-A7D559D1A714Q34983286-D2440601-FC29-466C-A93B-D5C3B90C3F95Q35161719-1763B6CC-AF32-40F3-9151-93FFBB258A21Q35629799-90E15949-F6ED-490E-AF08-21F9263B8A58Q35888659-F651675A-AE97-4310-A52E-96FA1A888C79Q36161792-10FF1746-7FD9-4543-B97A-AB2E297774B6Q36555908-FDD0194E-E2E8-41EB-A5F1-4ACDBBB0D2DEQ36812763-678FD30C-7F60-4BC7-A934-4D1B8E101C1CQ36877251-BCF151DE-559C-483B-B998-CC0C6A85B8E0Q37104528-974E690C-76DE-4ECC-BA94-FE642E2B812FQ37310278-4FB1C7C8-A95D-49DC-A44C-C58375958721Q37310442-F6DCD103-3D99-4E6E-AA85-D2649A02E923Q37369964-152836EF-5062-44AF-9355-39A3A8D4BCF7Q37459522-F0264829-9CFC-44E9-B961-CEEB06D67A90Q37510348-0DF6B9F5-61B4-4681-BFB6-572472BBEF25Q37558264-F3E45100-8EAD-4299-A250-AC23B0138C0CQ37633833-56D7A589-1263-4A10-B0C1-14E2B014951DQ37668262-B8BB752D-E7A9-4DF2-BBD1-B92D2C2B847AQ37801292-1FDB835E-A399-48EB-A5FD-6E9D11C04D89Q37923849-D0DB7185-3555-4E1A-A40D-D9F532A6290CQ37965656-9A4C8C19-319C-4DFC-BFF1-1E519B4B1D43Q39818869-010260B3-3AC1-4F98-8BDC-DB751810DF5DQ42156423-87CFBCA4-3BFE-4CE4-8BA8-CE92ADD421D1Q42668752-0074DD98-2A46-457F-B8A3-A76CA9F51C98Q43167309-1241D6FA-E226-40E3-97AC-6324B31D25FAQ43789284-C1CEEF0D-E6B4-42F3-B947-FBD18B2A81DAQ46083552-5EA1F59C-7024-47AC-A44C-C9062E91CBC6
P2860
Surrogate markers for cardiovascular disease: structural markers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Surrogate markers for cardiovascular disease: structural markers.
@ast
Surrogate markers for cardiovascular disease: structural markers.
@en
type
label
Surrogate markers for cardiovascular disease: structural markers.
@ast
Surrogate markers for cardiovascular disease: structural markers.
@en
prefLabel
Surrogate markers for cardiovascular disease: structural markers.
@ast
Surrogate markers for cardiovascular disease: structural markers.
@en
P1433
P1476
Surrogate markers for cardiovascular disease: structural markers.
@en
P2093
G B John Mancini
Javier Díez
P304
P356
10.1161/01.CIR.0000133443.77237.2F
P407
P433
25 Suppl 1
P50
P577
2004-06-01T00:00:00Z